NUT midline carcinoma – первый доказанный случай заболевания у ребенка в Республике Беларусь

NUT midline carcinoma (NMC) is a very rare, highly malignant disease with a specific cytogenetic abnormality t(15;19)(q14;p13.1). This tumor can occur throughout life, unfortunately, most cases are  characterized by the presence of metastases at the time of  diagnosis. There are clear cytogenetic and molecular-biological  criterias for diagnosis. There are no specific standards of therapy  that provide effective treatment of this pathology in the world.  However, the presence of a chimeric oncogene characterizing the  tumor is promising in terms of targeting drug research in the  framework of international cooperation. It is also necessary to collect information about this rare disease to analyze it and to identify the  most effective therapy method. This article presents an analysis of  the clinical case of NMC, first diagnosed in a child of 9-yearsold in the Republic of Belarus.